FDA NDC Directory · JSON-LD · Markdown

Darzalex Faspro

NDC 57894-503 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedaratumumab and hyaluronidase-fihj (human recombinant)
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761145
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDARATUMUMAB (1800 mg/15mL)
HYALURONIDASE (HUMAN RECOMBINANT) (30000 U/15mL)
Marketing started20200501
Package count1

External sources

Source: openFDA. Public-domain (CC0).